NORVIC FAMILY PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: M88009 | SMETHWICK, B66 3PZ
Showing results 51-100 of 614
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Influenza | 858 | 858 | £9.8K | -45.3% ▼ |
| Famotidine | 817 | 31.3K | £17.6K | +67.4% ▲ |
| Bendroflumethiazide | 811 | 29.8K | £473 | +4.9% ▲ |
| Senna | 767 | 59.7K | £1.5K | +27.5% ▲ |
| Insulin glargine | 750 | 3,496 | £26.0K | +164.2% ▲ |
| Quetiapine | 744 | 37.6K | £11.8K | +19.5% ▲ |
| Sildenafil (Erectile Dysfunction) | 744 | 5,966 | £1.8K | +47.6% ▲ |
| Folic acid | 742 | 47.0K | £2.4K | -42.8% ▼ |
| Latanoprost | 737 | 16.7K | £5.3K | +51.8% ▲ |
| Carbocisteine | 734 | 90.7K | £4.9K | +37.5% ▲ |
| Hydrocortisone | 713 | 22.6K | £4.2K | +59.0% ▲ |
| Venlafaxine | 708 | 26.9K | £5.6K | -16.2% ▼ |
| Levetiracetam | 702 | 63.9K | £7.3K | +53.3% ▲ |
| Linagliptin | 702 | 21.6K | £24.4K | +71.4% ▲ |
| Thiamine hydrochloride | 701 | 43.2K | £1.9K | +33.0% ▲ |
| Rosuvastatin calcium | 692 | 23.8K | £2.0K | -22.9% ▼ |
| Fluoxetine hydrochloride | 689 | 34.9K | £1.2K | -32.1% ▼ |
| Zopiclone | 640 | 8,254 | £526 | +15.6% ▲ |
| Alendronic acid | 635 | 2,896 | £1.1K | -15.3% ▼ |
| Rivaroxaban | 631 | 20.0K | £13.5K | +3.1% ▲ |
| Quinine sulfate | 625 | 19.4K | £3.4K | +115.9% ▲ |
| Candesartan cilexetil | 621 | 22.2K | £1.2K | -47.7% ▼ |
| Fexofenadine hydrochloride | 617 | 21.9K | £985 | -27.4% ▼ |
| Propranolol hydrochloride | 599 | 37.2K | £1.2K | -43.9% ▼ |
| Diclofenac diethyl | 592 | 59.7K | £5.4K | +66.7% ▲ |
| Doxycycline hyclate | 584 | 6,057 | £603 | +13.9% ▲ |
| Warfarin sodium | 580 | 15.7K | £3.4K | +23.0% ▲ |
| Ferrous sulfate | 577 | 35.9K | £1.2K | +12.2% ▲ |
| Ferrous fumarate | 553 | 77.7K | £2.2K | -23.7% ▼ |
| Nitrofurantoin | 538 | 7,561 | £3.9K | +12.7% ▲ |
| Lactulose | 528 | 262.2K | £2.5K | +60.4% ▲ |
| Lercanidipine hydrochloride | 527 | 23.0K | £2.3K | -14.7% ▼ |
| Alogliptin | 523 | 15.4K | £13.9K | +106.2% ▲ |
| Fluticasone propionate (Inhalation) | 503 | 551 | £13.7K | +30.0% ▲ |
| Mebeverine hydrochloride | 497 | 41.9K | £3.7K | +60.1% ▲ |
| Finasteride | 496 | 14.6K | £514 | -24.3% ▼ |
| Betamethasone valerate | 493 | 44.9K | £2.0K | +28.1% ▲ |
| Diazepam | 489 | 11.4K | £265 | -1.8% vs avg |
| Empagliflozin | 487 | 14.2K | £17.7K | -22.2% ▼ |
| Alginic acid compound preparations | 483 | 212.9K | £2.9K | -17.5% ▼ |
| 472 | 306.3K | £4.2K | +78.9% ▲ | |
| Cetirizine hydrochloride | 465 | 44.5K | £2.4K | -6.9% ▼ |
| Flucloxacillin sodium | 462 | 18.8K | £1.1K | +2.7% ▲ |
| Oxybutynin | 458 | 29.5K | £7.6K | +140.4% ▲ |
| Mometasone furoate | 457 | 477 | £3.7K | +13.8% ▲ |
| 452 | 4,335 | £2.3K | +81.2% ▲ | |
| Hydroxocobalamin | 449 | 1,061 | £2.2K | -6.7% ▼ |
| Spironolactone | 447 | 14.0K | £1.5K | -17.1% ▼ |
| Pizotifen malate | 438 | 18.7K | £798 | +431.4% ▲ |
| Duloxetine hydrochloride | 435 | 16.7K | £1.4K | -31.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.